Literature DB >> 28470556

Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factor-alpha and dexamethasone.

Menglin Xu1, Xiangdong Wang2.   

Abstract

Lung cancer is the leading cause of death from cancer. Mucins are glycoproteins with high molecular weight, responsible for cell growth, differentiation, and signaling, and were proposed to be correlated with gene heterogeneity of lung cancer. Here, we report aberrant expression of mucin genes and tumor necrosis factor receptors in lung adenocarcinoma tissues compared with normal tissues in GEO datasets. Mucin-1 (MUC1) gene was selected and considered as the target gene; furthermore, the expression pattern of adenocarcinomic cells (A549, H1650, or H1299 cells) was validated under the stimulation with tumor necrosis factor-alpha (TNFα) or dexamethasone (DEX), separately. MUC1 gene interference was done to A549 cells to show its role in sensitivity of lung cancer cells to TNFα and DEX. Results of our experiments indicate that MUC1 may regulate the influence of inflammatory mediators in effects of glucocorticoids (GCs), as a regulatory target to improve therapeutics. It shows the potential effect of MUC1 and GCs in lung adenocarcinoma (LADC), which may help in LADC treatment in the future.

Entities:  

Keywords:  Dexamethasone; Lung cancer; Mucin-1; Therapeutics; Tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2017        PMID: 28470556     DOI: 10.1007/s10565-017-9393-x

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  3 in total

Review 1.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

2.  MUC1 downregulation inhibits non-small cell lung cancer progression in human cell lines.

Authors:  Tao Xu; Daowei Li; Hongmei Wang; Taohua Zheng; Guangqiang Wang; Ying Xin
Journal:  Exp Ther Med       Date:  2017-08-29       Impact factor: 2.447

Review 3.  Is the clinical lipidomics a potential goldmine?

Authors:  Linlin Zhang; Xianlin Han; Xiangdong Wang
Journal:  Cell Biol Toxicol       Date:  2018-07-21       Impact factor: 6.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.